Question 1

What is cholestasis, progressive familial intrahepatic, 6?

Accepted Answer

Cholestasis, progressive familial intrahepatic, 6 is a liver disorder characterized by impaired bile flow leading to conjugated hyperbilirubinemia and a range of hepatic complications. The condition is caused by pathogenic variants in the SLC51A gene, which plays a key role in bile acid transport. It typically presents in early childhood with symptoms such as failure to thrive and liver dysfunction. The disorder is inherited in an autosomal recessive manner, and although precise prevalence data is not available, it is considered to be very rare.

Question 2

What are the symptoms of cholestasis, progressive familial intrahepatic, 6?

Accepted Answer

Individuals with cholestasis, progressive familial intrahepatic, 6 consistently exhibit a number of clinical features related to liver dysfunction. Characteristic findings include conjugated hyperbilirubinemia, intrahepatic cholestasis, failure to thrive, and chronic diarrhea. Additional features that are always present include elevated circulating levels of alkaline phosphatase, gamma-glutamyltransferase, and hepatic transaminases, along with periportal fibrosis, bleeding that may require red cell transfusion, and bruising susceptibility. Not all individuals experience every aspect to the same degree, and severity varies considerably.

Question 3

What causes cholestasis, progressive familial intrahepatic, 6?

Accepted Answer

Cholestasis, progressive familial intrahepatic, 6 is caused by pathogenic variants in the SLC51A gene, which is essential for normal bile acid transport through the liver. Disruption of this gene’s function leads to impaired bile flow and the subsequent development of liver-related symptoms. The condition is inherited in an autosomal recessive pattern, meaning that affected individuals have inherited two altered copies of the gene, one from each parent. This also implies that siblings have a recurrence risk, and genetic counseling is advised for families to understand these implications. Associated genes include SLC51A.

Question 4

How is cholestasis, progressive familial intrahepatic, 6 inherited?

Accepted Answer

cholestasis, progressive familial intrahepatic, 6 follows an autosomal recessive inheritance pattern. This means a child must inherit a copy of the altered gene from both parents to develop the condition. Parents who each carry one copy typically do not show symptoms.

Question 5

How is cholestasis, progressive familial intrahepatic, 6 diagnosed?

Accepted Answer

Definitive diagnosis is established through molecular genetic testing that identifies pathogenic variants in the SLC51A gene. In addition to genetic testing, clinical evaluation—focusing on hallmark signs such as conjugated hyperbilirubinemia, intrahepatic cholestasis, and liver dysfunction—supports the diagnosis. Because many features can overlap with other liver disorders, genetic confirmation is essential in distinguishing this condition from others with similar clinical presentations.

Question 6

Are there treatments for cholestasis, progressive familial intrahepatic, 6?

Accepted Answer

Currently, management of cholestasis, progressive familial intrahepatic, 6 focuses on supportive care and symptom management, as there are no FDA-approved treatments available. Treatment is tailored to the individual and typically involves a multidisciplinary team to address complications such as bleeding, nutritional deficits, and liver dysfunction. Regular monitoring and proactive management of symptoms are crucial. Genetic counseling is recommended to help families understand inheritance patterns and plan for the future, and patients should discuss available care strategies with their healthcare team.

Question 7

Are there clinical trials for cholestasis, progressive familial intrahepatic, 6?

Accepted Answer

Yes, there is currently 1 active clinical trial for cholestasis, progressive familial intrahepatic, 6 registered on ClinicalTrials.gov. Clinical trials test new treatments, procedures, or approaches. Your healthcare provider can help determine if a trial might be appropriate for your situation. Visit the Treatment section of this page for more details.

Question 8

What complications can arise from cholestasis, progressive familial intrahepatic, 6?

Accepted Answer

Cholestasis, progressive familial intrahepatic, 6 can lead to several complications related to liver dysfunction. These may include severe bleeding that could require red cell transfusions, chronic diarrhea, and nutritional deficits. The condition can also cause liver damage, which may progress over time, so regular monitoring and supportive care are essential.

Question 9

How does cholestasis, progressive familial intrahepatic, 6 affect daily life for patients?

Accepted Answer

Living with cholestasis, progressive familial intrahepatic, 6 can impact daily life in various ways. Patients may experience symptoms like failure to thrive and chronic diarrhea, which can affect energy levels and overall well-being. Supportive care and symptom management are important, and families often work closely with healthcare teams to address these challenges.

Question 10

What is the life expectancy for someone with cholestasis, progressive familial intrahepatic, 6?

Accepted Answer

The life expectancy for individuals with cholestasis, progressive familial intrahepatic, 6 can vary widely. It largely depends on the severity of liver involvement and how well symptoms are managed. With timely and appropriate supportive care, many individuals can lead fulfilling lives, but ongoing monitoring is crucial to address any complications that may arise.

Question 11

What specialists should families consult for cholestasis, progressive familial intrahepatic, 6?

Accepted Answer

Families dealing with cholestasis, progressive familial intrahepatic, 6 should consult a team of specialists, including a pediatric hepatologist for liver care and a genetic counselor for understanding inheritance patterns. A multidisciplinary approach is often beneficial, involving nutritionists and other healthcare providers to manage symptoms and complications effectively.

Kisho

cholestasis, progressive familial intrahepatic, 6

Overview

Clinical Presentation

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Medical References

External Resources

OMIM

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

Explore clinical features

Recent Publications

cholestasis, progressive familial intrahepatic, 6

Overview

Clinical Presentation

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Medical References

External Resources

OMIM

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is cholestasis, progressive familial intrahepatic, 6?

What are the symptoms of cholestasis, progressive familial intrahepatic, 6?

What causes cholestasis, progressive familial intrahepatic, 6?

How is cholestasis, progressive familial intrahepatic, 6 inherited?

How is cholestasis, progressive familial intrahepatic, 6 diagnosed?

Are there treatments for cholestasis, progressive familial intrahepatic, 6?

Are there clinical trials for cholestasis, progressive familial intrahepatic, 6?

What complications can arise from cholestasis, progressive familial intrahepatic, 6?

How does cholestasis, progressive familial intrahepatic, 6 affect daily life for patients?

What is the life expectancy for someone with cholestasis, progressive familial intrahepatic, 6?

What specialists should families consult for cholestasis, progressive familial intrahepatic, 6?

Explore clinical features

Recent Publications